Glucagon-like peptide 2 in colon carcinogenesis: possible target for anti-cancer therapy? (2013)
Source: Pharmacology and Therapeutics. Unidade: FMRP
Subjects: NEOPLASIAS DO COLON (TERAPIA), PEPTÍDEOS, GLUCAGON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KANNEN, Vinicius et al. Glucagon-like peptide 2 in colon carcinogenesis: possible target for anti-cancer therapy?. Pharmacology and Therapeutics, v. 139, n. 1, p. 87\201394, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.pharmthera.2013.04.007. Acesso em: 30 set. 2024.APA
Kannen, V., Garcia, S. B., Stopper, H., & Waaga-Gasser , A. M. (2013). Glucagon-like peptide 2 in colon carcinogenesis: possible target for anti-cancer therapy? Pharmacology and Therapeutics, 139( 1), 87\201394. doi:10.1016/j.pharmthera.2013.04.007NLM
Kannen V, Garcia SB, Stopper H, Waaga-Gasser AM. Glucagon-like peptide 2 in colon carcinogenesis: possible target for anti-cancer therapy? [Internet]. Pharmacology and Therapeutics. 2013 ; 139( 1): 87\201394.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.pharmthera.2013.04.007Vancouver
Kannen V, Garcia SB, Stopper H, Waaga-Gasser AM. Glucagon-like peptide 2 in colon carcinogenesis: possible target for anti-cancer therapy? [Internet]. Pharmacology and Therapeutics. 2013 ; 139( 1): 87\201394.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.pharmthera.2013.04.007
